24 May 2013
Keywords: vismed, enters, trial, dry, eye, syndrome, usa-based
Article | 22 January 2007
USA-based drug development firm Lantibio and Swiss pharmaceutical company TRB Chemedica have initiated a Phase III clinical trial of the
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
21 May 2007
23 May 2013
© 2013 thepharmaletter.com